Welcome to our dedicated page for Horizon Techn news (Ticker: HRZN), a resource for investors and traders seeking the latest updates and insights on Horizon Techn stock.
Horizon Technology Finance Corporation (HRZN) provides venture lending and growth-capital financing to development-stage and growth companies in technology, life science, healthcare information and services, and sustainability. Its recurring announcements address secured loan facilities, portfolio activity, net investment income and NAV, monthly cash distributions and special distributions, and capital allocation by its board.
Company updates also cover its external management by Horizon Technology Finance Management LLC, affiliation with Monroe Capital, the completed merger with Monroe Capital Corporation, and the HRZN CRFH LLC joint venture focused on growth financing for small- and micro-cap public companies.
Horizon Technology Finance (NASDAQ: HRZN) reported Q4 2025 net investment income (NII) of $8.3M ($0.18/share) and NAV of $318.5M ($6.98/share) as of December 31, 2025. Annualized debt portfolio yield was 14.3% for Q4 and 15.8% for full-year 2025.
The Company ended 2025 with a total portfolio of $647.2M, committed backlog of $154M, cash of $142.7M, credit facility capacity of $329.0M, and undistributed spillover income of $0.65/share. The Board declared monthly distributions of $0.06/share for April–June 2026 and continues progress toward the anticipated merger with MRCC.
Horizon Technology Finance (NASDAQ: HRZN) will release fourth-quarter 2025 financial results for the period ended December 31, 2025 on March 3, 2026 after market close. A conference call to discuss results is scheduled for March 4, 2026 at 9:00 a.m. ET.
Executives participating include Mike Balkin (CEO), Paul Seitz (SVP & CIO), and Dan Trolio (EVP & CFO). The call is accessible by phone and via a live listen-only webcast on the company website; an online archive will be available for 30 days.
Horizon Technology Finance (NASDAQ: HRZN) and Monroe Capital closed an initial $40 million senior credit facility for Ossio Inc., with an additional $10 million available to support future growth. The financing aims to accelerate OSSIO’s global expansion of its metal-free OSSIOfiber bone regeneration technology, with development and manufacturing in Caesarea, Israel, and commercial operations in Palmetto, FL.
This growth capital positions OSSIO to scale commercialization while Horizon and Monroe provide strategic healthcare and Israeli technology ecosystem expertise.
Horizon Technology Finance (Nasdaq: HRZN) priced a registered direct offering of $57.50 million aggregate principal amount of 7.00% Notes due December 15, 2028. Interest is 7.00% annually, payable June 15 and December 15, beginning December 15, 2025. The Notes may be redeemed prior to June 15, 2028 at par plus a make-whole premium and thereafter at par plus accrued interest.
The company expects delivery on or about December 15, 2025, with Oppenheimer & Co. as sole book-running manager. The company intends to use net proceeds to repay indebtedness, including its 4.875% Notes due 2026, and for general corporate purposes. The Notes are not expected to be listed.
Horizon Technology Finance (NASDAQ: HRZN) declared monthly cash distributions of $0.11 per share payable on January 15, 2026, February 13, 2026, and March 13, 2026, totaling $0.33 per share for the first quarter of 2026.
The Board based the declaration on third quarter operating results and spillover income, and said it will reassess distributions in February 2026 after fourth quarter 2025 results and spillover at December 31, 2025, taking into account the anticipated merger with Monroe Capital. Since its 2010 IPO, Horizon has paid $340 million in distributions. Horizon offers a Dividend Reinvestment Plan that may issue new shares or use open-market purchases to satisfy reinvestment.
Horizon Technology Finance (NASDAQ: HRZN) reported results for Q3 2025: Net investment income $14.0M ($0.32/sh), NAV $315.7M ($7.12/sh), and an annualized debt portfolio yield of 18.6%. Total investment portfolio was $603.5M and Horizon ended the quarter with a committed backlog of $119M. Cash was $130.9M with available credit capacity of $329.0M. The company purchased a co-lender portfolio for $22.5M (fair value $36.5M), raised approx. $10.6M via ATM sales, and issued $40M of 5.50% convertible notes. Undistributed spillover income was $0.93/sh and Horizon declared monthly distributions totaling $0.33/sh through March 2026.
Horizon Technology Finance (NASDAQ: HRZN) will release third quarter results for the period ended September 30, 2025 on Tuesday, October 28, 2025 after market close.
The company will host a conference call to discuss results on Wednesday, October 29, 2025 at 9:00 a.m. ET with CEO Mike Balkin, CIO Paul Seitz, and CFO Dan Trolio. Dial-in numbers: (877) 407-9716 (domestic) or (201) 493-6779 (international); Conference ID 13755891. A live listen-only webcast will be available at www.horizontechfinance.com and archived for 30 days.
Horizon Technology Finance (NASDAQ: HRZN) has declared monthly cash distributions of $0.11 per share for October, November, and December 2025, totaling $0.33 per share. The distributions will be paid on October 15, November 14, and December 16, 2025.
Since its IPO in 2010, Horizon has distributed a total of $326 million to shareholders. The company maintains a Dividend Reinvestment Plan (DRIP) that automatically reinvests distributions into additional shares unless stockholders opt out. DRIP shares can be sourced through new issuance or open market purchases.
Horizon Technology Finance (NASDAQ: HRZN) reported its Q2 2025 financial results and announced a significant merger with Monroe Capital Corp (NASDAQ: MRCC). The company posted net investment income of $11.4 million ($0.28 per share), down from $12.9 million ($0.36 per share) in Q2 2024. The total investment portfolio stood at $622.7 million with a debt portfolio yield of 15.8%.
Key highlights include funding of seven loans totaling $59.7 million, liquidity events from seven portfolio companies, and an increased debt facility commitment of $100 million. The company's NAV decreased to $6.75 per share from $9.12 year-over-year, primarily due to challenging venture capital conditions. HRZN maintained strong liquidity with $81.2 million in cash and $329.0 million in credit facility capacity.
The company declared monthly distributions of $0.11 per share through December 2025 and reported undistributed spillover income of $0.94 per share.
Monroe Capital Corporation (NASDAQ: MRCC) has announced a significant strategic merger with Horizon Technology Finance Corporation (NASDAQ: HRZN). The transaction involves two key steps: First, Monroe Capital Income Plus Corporation (MCIP) will acquire MRCC's assets at fair value. Subsequently, MRCC will merge with HRZN in a NAV-for-NAV exchange, with HRZN as the surviving entity.
The merger will create a combined entity with approximately $446 million in NAV, with former MRCC shareholders owning about 37% of HRZN. Key benefits include enhanced scale, operational cost savings, and improved trading liquidity. HTFM has agreed to a $4 million fee waiver over the first four quarters post-closing. The transaction is expected to close in Q4 2025, subject to shareholder and regulatory approvals.